BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//wp-events-plugin.com//6.0.1.1//EN
BEGIN:VEVENT
UID:d81f427a-0b77-4e07-ada4-5b669b51b5e1
DTSTART:20261020T080000Z
DTEND:20261022T151000Z
DTSTAMP:20261006T000032Z
SUMMARY:4th Covalent Drug Discovery and Development Summit
DESCRIPTION:Covalent drug discovery has entered a defining new phase where scientific validation is no longer the primary barrier\; successful clinical translation now takes center stage.\n\nOnce limited by concerns around off-target toxicity\, covalent approaches are now unlocking undruggable targets and expanding beyond oncology into new therapeutic areas. As next-generation warheads\, chemoproteomics\, and AI-driven design accelerate innovation\, the key challenge is clear: how to translate covalent candidates into safe\, effective clinical therapies.\n\nThe 4th Covalent Drug Discovery and Development Summit is the only industry forum dedicated to advancing covalent therapeutics end-to-end\, from discovery through to IND and early clinical development.\n\nUniting experts from Bristol Myers Squibb\, Novartis\, Pfizer\, Biogen\, Nexo Therapeutics\, and Frontier Medicines\, this summit goes beyond high-level discussion to deliver data-driven case studies\, translational strategies\, and real clinical insights.\n\nJoin 80+ covalent leaders to:\n\nDe-risk your pipeline with early clinical and translational learnings\nOvercome selectivity\, safety\, and PK/PD challenges\nGain candid insights not found in publications\nAs more covalent drugs enter the clinic\, now is the time to turn promise into proof.
LOCATION:Hampton Inn Boston Seaport District\, 670 Summer Street\, Boston\, Massachusetts\, 02210\, United States
URL:https://eventstopten.com/events/4th-covalent-drug-discovery-and-development-summit/
END:VEVENT
END:VCALENDAR